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Heart development
Cardiac progenitor cell
Outﬂow tractAt the end of the ﬁrst week of mouse gestation, cardiomyocyte differentiation initiates in the cardiac crescent
to give rise to the linear heart tube. The heart tube subsequently elongates by addition of cardiac progenitor
cells from adjacent pharyngeal mesoderm to the growing arterial and venous poles. These progenitor cells,
termed the second heart ﬁeld, originate in splanchnic mesoderm medial to cells of the cardiac crescent and
are patterned into anterior and posterior domains adjacent to the arterial and venous poles of the heart, re-
spectively. Perturbation of second heart ﬁeld cell deployment results in a spectrum of congenital heart anom-
alies including conotruncal and atrial septal defects seen in human patients. Here, we brieﬂy review current
knowledge of how the properties of second heart ﬁeld cells are controlled by a network of transcriptional
regulators and intercellular signaling pathways. Focus will be on 1) the regulation of cardiac progenitor
cell proliferation in pharyngeal mesoderm, 2) the control of progressive progenitor cell differentiation and
3) the patterning of cardiac progenitor cells in the dorsal pericardial wall. Coordination of these three pro-
cesses in the early embryo drives progressive heart tube elongation during cardiac morphogenesis. This arti-
cle is part of a Special Issue entitled: Cardiomyocyte Biology: Cardiac Pathways of Differentiation, Metabolism
and Contraction.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Morphogenesis of the embryonic heart occurs progressively be-
tween day 7 and day 10 of mouse gestation. During this period, the ear-
liest cardiomyocytes differentiate in lateral anterior splanchnic
mesoderm to form the cardiac crescent underlying the head folds [1].
The cardiac crescent gives rise to the linear heart tube, with a posterior
venous pole and anterior arterial pole, that rapidly elongates and un-
dergoes rightward looping to generate the embryonic heart tube by
mid-gestation. Subsequently, cardiac septation takes place, generating
the right and left atrial and ventricular chambers and converting the cy-
lindrical myocardial outﬂow tract into the ascending aorta, outlet of the
left ventricle, and the pulmonary trunk, outlet of the right ventricle. The
process of heart tube extension is essential to generate the template for
cardiac septation. Thus defects in either the septation process itself, or
prior heart tube elongation, lead to failure to separate systemic and pul-
monary circulatory systems, resulting in life-threatening congenital
heart anomalies [2].rdiomyocyte Biology: Cardiac
tion.
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rights reserved.Heart tube elongation is driven by the addition of cardiac progen-
itor cells to the arterial and venous poles of the heart tube. These pro-
genitor cells are situated in medial splanchnic pharyngeal mesoderm
and have been termed the second heart ﬁeld [3–5]. Here, we brieﬂy
discuss how a network of intercellular signals and transcriptional reg-
ulators control the properties of second heart ﬁeld cells, including
continued proliferation and delayed differentiation. In addition, we
review new insights into how the progenitor cell ﬁeld is patterned.
Integration of these processes drives progressive heart tube elonga-
tion during cardiac morphogenesis.
2. The regulation of proliferation in the dorsal pericardial wall
Progressive restriction of mesodermal precursor cells to a myocar-
dial fate initiates with expression of the transcriptional regulator
Mesp1 in anterior mesoderm, followed by activation of a combinato-
rial code of cardiac transcription factor encoding genes including
Nkx2-5, Mef2c, Gata4 and Baf60c and rapid differentiation of the ﬁrst
cardiomyocytes in the cardiac crescent [1]. Cells expressing the tran-
scription factor Isl1 in pharyngeal mesoderm medial to the cardiac
crescent continue to proliferate and contribute to growth of the myo-
cardium [6]. Initially, these cells contribute throughout the length of
the forming heart tube, across the dorsal mesocardium. After break-
down of this structure and closure of the dorsal side of the heart
Fig. 2. Cartoon showing the major signaling pathways known to control proliferation
and progressive differentiation of second heart ﬁeld cardiac progenitor cells in the
early embryo. See text for details.
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the dorsal pericardial wall and contribute to the growing heart tube
by addition at the poles (Fig. 1). Studies from the Moorman group
in the chick embryo and recently in the mouse have revealed ex-
tremely high rates of proliferation in the dorsal pericardial wall dur-
ing heart tube extension [7,8]. In the chick embryo, the proliferative
center is positioned caudally and cells have been estimated to move
from this proliferative center towards the poles of the heart tube at
a rate of 70 μm/h [7]. Upon differentiation, cell division rates dramat-
ically drop, to be resumed during the process of cardiac chamber for-
mation. In the mouse, the entire dorsal pericardial wall has been
found to proliferate at a high rate, with cell division rates decreasing
as cells differentiate at the poles of the heart tube [8].
Proliferation of cardiac progenitor cells in the dorsal pericardial
wall appears to be driven by ﬁbroblast growth factor (FGF) signaling
(Fig. 2). FGF ligands implicated in second heart ﬁeld development in-
clude Fgf3, Fgf8 and Fgf10 [9–12]. FGF ligands are expressed in pha-
ryngeal mesoderm and adjacent pharyngeal epithelia including
ventral pharyngeal endoderm and lateral ectoderm. Fgf8, within pha-
ryngeal mesoderm, appears to be the major driver of heart tube ex-
tension, with compound mutant analysis revealing roles for Fgf3
and Fgf10. FGF ligand expression in the pharyngeal region is regulat-
ed by Wnt/β-catenin and Notch signaling [13–15]. Conditional
loss-of-function analysis of these signaling pathways in the second
heart ﬁeld results in shortening of the cardiac outﬂow tract leading
to subsequent arterial pole septation defects [9,14–16]. In addition,
inﬂux of neural crest cells into the caudal pharyngeal regions modu-
lates local FGF signaling and leads to decreased proliferation in the
second heart ﬁeld, potentially acting as a proliferative brake during
the terminal stages of heart tube elongation [17]. Wnt/β-catenin sig-
naling has recently been shown to operate downstream of Notch in
the regulation of progenitor cell differentiation and outﬂow tract
morphogenesis [15]. Proximity to the underlying ventral pharyngeal
endoderm is likely to be an essential factor in maintaining progenitor
cell properties of second heart ﬁeld cells in the dorsal pericardial
wall. Ventral endoderm is a source of Hedgehog (Hh) signaling that
also positively regulates proliferation in the dorsal pericardial wall
of avian embryos and is required for second heart ﬁeld deployment
in the mouse [18,19]. Hh signaling has been shown to regulate
progenitor cell proliferation in the posterior SHF in part through the
transcription factor Tbx5, in a pathway essential for atrial septation
[20].
Signal emission and reception during this process are regulated by a
number of key transcription factors, including the LIM-homeodomain
protein Isl1, that controls Wnt and FGF ligand gene expression, and
the T-box transcription factor Tbx1, that regulates FGF ligand expres-
sion as well as FGF signal response [6,21,22]. TBX1 is the major candi-
date gene for DiGeorge syndrome in man, associated with craniofacial
and cardiovascular anomalies including conotruncal congenital heartFig. 1. Second heart ﬁeld cardiac progenitor cells are situated in the dorsal wall of the
pericardial cavity during heart tube extension. Cartoons showing a left lateral view
(left) and mid-sagittal section (right) of the pharyngeal region of a mouse embryo at
embryonic day 9.5. Note the localization of the anterior and posterior domains of the
second heart ﬁeld in the dorsal pericardial wall.
Adapted from [5].defects [23]. In mouse embryos lacking Tbx1, the dorsal pericardial
wall is hypoplastic due to decreased proliferation in pharyngeal meso-
derm at day 8.5 of development [24]. The reduction in cardiac progeni-
tor cells associated with decreased proliferation results in a short
narrow outﬂow tract at midgestation [24,25,26]. The transcription fac-
tors Six1 and Eya1 appear to play an intermediate role in the activation
of Fgf8 downstreamof Tbx1 [27].Hes1, a target gene of theNotch signal-
ing pathway, is expressed in the dorsal pericardial wall and is required
for maximal progenitor cell proliferation [28]. Elevated expression of
the CDK inhibitor p27Kip1 inHes1 null embryos suggests that Hes1 pre-
vents precocious differentiation in the dorsal pericardial wall. Besides
proliferation, cell survival is an important regulatory step in SHF devel-
opment and the bHLH transcription factor Hand2 has been implicated
in this process [29].
3. The control of progressive differentiation during heart
tube elongation
As cells in the dorsal pericardial wall contribute to the poles of the
heart tube, decreased proliferation coincides with the onset of myo-
cardial differentiation. There appears to be a sharp transition between
undifferentiated progenitor cells in the dorsal pericardial wall and
differentiated cardiomyocytes in the outﬂow tract. At the arterial
pole of the heart, differentiation is driven by BMP signaling from the
distal outﬂow tract. BMP signaling promotes differentiation in part
by antagonizing pro-proliferative FGF signals, potentially via activat-
ing BMP target genes such as Msx1 in neural crest-derived cells
(Fig. 2) [30,31]. BMP signaling also activates transcription of
microRNAs that speciﬁcally target progenitor cell transcripts such as
those encoding Isl1 and Tbx1 [32]. Proximal to the heart tube, cardiac
progenitor cells initiate expression of genes encoding key cardiac
transcription factors including Nkx2-5, Tbx20, Mef2c, Gata4 and
Hand2, combinatorially required to activate the cardiomyogenic ge-
netic program [33]. Loss of function of Nkx2-5 leads to
overspeciﬁcation of cardiac progenitor cells in pharyngeal mesoderm
through upregulation of the chromatin regulator Jarid2 and BMP li-
gand gene expression [34,35]. Elevated BMP signaling in Nkx2-5 null
embryos, in turn, causes decreased proliferation in the second heart
ﬁeld. BMP signaling in the distal outﬂow tract region is
downregulated in embryos lacking the T-box transcription factors
Tbx2 and Tbx3, resulting in elevated FGF signaling proximal to the
outﬂow tract [36]. These T-box factors, together with Tbx1, constitute
a regulatory network upstream of the signaling axis controlling pro-
liferation and differentiation of cardiac progenitor cells during heart
tube extension. Loss of function of any two of these three genes re-
sults in severely altered BMP and FGF signaling, pharyngeal
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important role in regulating cardiac progenitor cell differentiation. In
Tbx1mutant embryos, abnormal activation of differentiation markers
is observed in the dorsal pericardial wall, while gain of Tbx1 function
causes reduction of differentiation markers in the outﬂow tract [37].
Tbx1 has been shown to prevent progenitor cell differentiation by di-
verse molecular mechanisms, including 1) direct interaction with
Smad1 causing inhibition of BMP target gene activation, 2) direct in-
teraction with SRF, a transcription factor involved in cardiomyocyte
differentiation that appears to be targeted for degradation in the pres-
ence of Tbx1, and 3) transcriptional repression of Mef2c, required to
initiate myogenic differentiation [38,37,39]. Tbx1 thus occupies a
nodal position in the positive regulation of proliferation and negative
regulation of differentiation in the second heart ﬁeld (Fig. 2). In con-
trast to Tbx1, Isl1 appears to be maintained in the distal outﬂow tract
and to contribute to the differentiation program through activation of
Mef2c [40]. Consistent with this ﬁnding, misexpression of Isl1 in dif-
ferentiated cardiomyocytes does not block differentiation [41]. Isl1
expression is negatively regulated by continued Wnt/β-catenin sig-
naling, that is in turn inhibited by pro-differentiation non-canonical
Wnt ligands Wnt5a and Wnt11 [42].Wnt5a has recently been identi-
ﬁed as a Tbx1 target gene, dependent on interactions between Tbx1
and components of a chromatin remodeling complex, and loss of
Tbx1 and Wnt5a causes severe hypoplasia of second heart ﬁeld de-
rived regions of the heart [43]. In addition to the above signaling
pathways, continued activation of Mef2c in cardiac progenitor cells
requires retinoic acid signaling, potentially mediated via Gata4 [44].
Retinoic acid signaling may therefore play a role in the maintenance
of progenitor cell populations in the dorsal pericardial wall [44].
4. Patterning of cardiac progenitor cells in the dorsal
pericardial wall
Cardiac progenitor cells in the dorsal pericardial wall are thus reg-
ulated by a complex interplay of intercellular signals and transcrip-
tion factors, the integrated action of which promotes proliferation
and controls progressive differentiation (Fig. 2). In addition, cardiac
progenitor cells in the dorsal pericardial wall become patterned
such that two populations of cells can be distinguished: the anterior
second heart ﬁeld adjacent to the arterial pole and the posterior sec-
ond heart ﬁeld adjacent to the venous pole (Fig. 1). Ultimately, de-
scendants of these progenitor cell subpopulations give rise to right
ventricular and outﬂow tract myocytes and atrial (including atrial
septum) myocytes. Different genetic markers have been identiﬁed
that distinguish these populations of progenitor cells and thus provide
a read-out of anterior–posterior patterning in pharyngeal mesoderm.
These include Fgf10 and a Mef2c enhancer transgene expressed in
the anterior second heart ﬁeld, and Tbx5 and Osr1 expressed in the
posterior second heart ﬁeld (reviewed in [5]). Cre lineage analysis
using the Mef2c enhancer suggests that cells at the border between
the anterior and posterior domains contribute to both poles of the
heart [45]. This is supported by analysis of the contribution of progen-
itor cells expressing anterior Hox genes to the developing heart [46].
Hox genes are important regulators of anterior–posterior positional in-
formation in the developing embryo; Hoxb1-Cre lineage labeled cells
contribute to atrial myocardium and also to the inferior wall of the
outﬂow tract, and ultimately to myocardium at the base of the outlet
of the right ventricle, or sub-pulmonary myocardium [46]. Consistent
with these observations, recent diI labeling experiments in the mouse
have identiﬁed a contribution of posterior SHF cells to the arterial pole
of the heart and retrospective clonal analysis has shown that venous
pole and subpulmonary myocytes are clonally related [47,48]. Future
subpulmonary myocardium appears to be particularly dependent on
Tbx1 function, consistent with analysis of Tbx1-Cre lineage contribu-
tions to the inferior wall of the developing outﬂow tract [49,50]. Inter-
estingly, failure of subpulmonary myocardial development in Tbx1null embryos is associated with abnormal expression of an Fgf10
transgene in myocardium at the venous pole of the heart [25]. This
observation suggests that Tbx1 plays a role not only in coordinating
proliferation and differentiation delay, but also in patterning of cardiac
progenitor cells in the dorsal pericardial wall.
5. Conclusions
A complex network of signals and transcription factors regulates
the properties of cardiac progenitor cells in the early mouse embryo
during heart tube elongation, an essential step in morphogenesis of
the deﬁnitive heart. These events are integrated with patterning of
cardiac progenitor cells along different axes: the medial–lateral axis,
more medial pharyngeal mesodermal cells contributing to later
growth of the heart tube, and the anterior–posterior axis, anterior
progenitor cells contributing to the arterial pole and posterior pro-
genitor cells to the venous pole and subpulmonary myocardium.
Our understanding of how addition of progenitor cells to the heart
tube is regulated remains nevertheless rudimentary and the mecha-
nisms by which proliferation, differentiation and patterning are coor-
dinated is the subject of extensive ongoing research. In addition, how
cardiac progenitor cells behave during the dynamic process of heart
tube elongation is unknown. Finally, the study of the maintenance
and progressive differentiation of cardiac progenitor cells in the
early embryo may provide insights into promoting myocardial repair
of the damaged heart.
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